Study reveals antidepressants most common medication for Australian women

Dec 16, 2008

(PhysOrg.com) -- A new study has revealed the most commonly prescribed medication for Australian women is antidepressants. The study, by researchers from Australian Longitudinal Study on Women's Health (ALSWH).

Pharmaceutical Benefits Scheme and Medicare data were linked to survey data to examine claims and costs of medications and other health care resources.

University of Newcastle study co-director and lead author of the Use and costs of medications and other health care resources report, Professor Julie Byles, said the research indicated the prevalence of antidepressant use increased with age.

“Eight percent of younger women and 14 percent of mid-age women used antidepressants during the surveyed period," Professor Byles said.

"This figure jumps to 18 percent in older women."

“However, the use of antidepressants is not a clear indicator of the extent of depression among women. For example, among young women who reported a diagnosis of depression, 40 percent had not used prescribed antidepressant medication.”

Other significant findings from the research include:

• Older women, in particular, mentioned the impact of of costs of medication on their ability to manage their incomes
• There were few differences in patterns of claims between women living in urban, rural and remote areas
• There was evidence that women who made claims for common medications had a lower socio-economic status.

The release of the report coincides with the Australian Government's announcement of a further $5 million to continue the longitudinal study for the next three and a half years. ALSWH has been funded by the Department of Health and Ageing since it commenced in 1996.

UQ ALSWH Director, Professor Annette Dobson, said the research provided an evidence-base to Government to assist health policy and programs to keep pace with the evolving needs of Australian women.

“The ongoing support of the Australian Government means the study's findings can continue to provide an invaluable insight into the biological, psychosocial and environmental factors affecting women across the course of life," Professor Dobson said.

The ALSWH is a 20 year project involving three cohorts spanning three generations. More than 40,000 women participate in the study. Researchers based in Newcastle work in collaboration with the Hunter Medical Research Institute. Use and costs of medications and other health care resources are available at www.alswh.org.au .

Provided by UQ

Explore further: Vaccine for West Nile Virus enters human clinical trials

Related Stories

Childcare norms change as society industrialises

Jun 24, 2015

A study of childcare across societies has found a range of factors influence women's decisions to engage in childcare activities in industrialised societies, but in small-scale societies, their decisions ...

Japan's whaling science under the microscope

May 20, 2015

When Japanese researchers said earlier this year that eating whale meat could help prevent dementia and memory loss, the news provoked snorts of derision—it couldn't be real science, went the retort.

More cycling with e-bikes

May 20, 2015

According to a new study, electric bikes make people cycle longer and more often. The effect is best on women.

Women still find it tough to reach the top in science

Mar 24, 2015

Women are playing an increasing role in science today but there are still barriers that can prevent them from achieving success comparable to their male colleagues. This feeds the argument that there is a ...

Research identifies barriers to ethical buying

Feb 16, 2015

We know consumers buy ethical products for a range of reasons, from concerns about animal welfare to their own health, but Australian research has for the first time ranked the relative importance of the ...

Recommended for you

Vaccine for West Nile Virus enters human clinical trials

12 minutes ago

A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.